Novus Biologicals™ LXR beta/NR1H2 Antibody Blocking Peptide

Catalog No.	Quantity
NBP176256E	0.05 mg

Catalog No. NBP176256E Supplier Novus Biologicals™ Supplier No. NBP176256PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 14 amino acids near the amino terminus of human LXR-B. Source: Synthetic (Accession #: P55055) The LXR beta/NR1H2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 7376
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76256. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: Liver x receptor beta, LXR-b, NER-I, NERliver x receptor-beta, nuclear orphan receptor LXR-beta, Nuclear receptor NER, Nuclear receptor subfamily 1 group H member 2, nuclear receptor subfamily 1, group H, member 2, oxysterols receptor LXR-beta, RIP15, steroid hormone-nuclear receptor NER, Ubiquitously-expressed nuclear receptorLXRB, UNRLX receptor beta
• Gene Symbol: NR1H2
• Product Type: LXR beta/NR1H2
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 14 amino acids near the amino terminus of human LXR-B